Skip to content

Ranitidine

Zantac (ranitidine) is a small molecule pharmaceutical. Ranitidine was first approved as Zantac on 1983-06-09. It is used to treat duodenal ulcer, gastroesophageal reflux, peptic esophagitis, stomach ulcer, and zollinger-ellison syndrome in the USA. The pharmaceutical is active against histamine H2 receptor.
Trade Name Zantac
Common Name Ranitidine
Indication duodenal ulcer, gastroesophageal reflux, peptic esophagitis, stomach ulcer, zollinger-ellison syndrome
Drug Class H2-receptor antagonists (cimetidine type)
Ranitidine
Get full access now